B-MoGen Biotechnologies is a Genome Engineering Company with novel Intellectual Property that has been spun out of the University of Minnesota.
B-MoGen Biotechnolgies is a recently formed company that provides Genome Engineering Products and Services for the Tools and Reagents marketplace. We bring the next generation of genetic engineering techniques and methods that help drug discovery, antibody companies and cellular therapy companies reduce their overall cost of delivery. Our unique capability is, we deliver your favorite gene in your favorite cell. Others cannot make that claim!